Introduction
Karyotype analysis of cultured cells has been considered as the gold standard for prenatal diagnosis for the last 35 years to detect copy number and large structural chromosomal abnormalities. Many critical deletions or rearrangements may account for different pathologies and could not be detected through conventional techniques. In the last 10 years, new insights into the cytogenetics area launched novel molecular DNA-based techniques such as fluorescence in situ hybridization (FISH), spectral karyotyping (SKY), comparative genomic hybridization (CGH) and microarrays [1] [2] [3] . These techniques alone or combined with conventional karyotyping allow rapid and assertive diagnosis of selected cases.
CGH was first proposed in 1992 [2] and it is a widegenome screening test based in a competitive hybridization between a test and a normal DNA. The use of CGH in prenatal diagnosis has been increasing in the last years. Recent research in the area has focused in trisomy 21 detection in maternal blood using CGH [4] and detection of other structural chromosomal abnormalities in dysmorphic fetuses [5] [6] [7] .
Congenital abdominal wall defects are usually associated with environmental factors, although genetic factors cannot be totally overruled. Although many authors have shown that fetuses with gastroschisis are usually reported with normal karyotype [8] , the resolution level of conventional cytogenetics techniques may underrepresent small structural abnormalities. The aim of this study was to investigate whether molecular investigation through CGH could improve the resolution of the cytogenetics reports and show abnormalities not seen through conventional techniques.
Materials and Methods
A descriptive study was carried out including fetuses with ultrasonographic gastroschisis diagnosis, from January 2005 to January 2006. Ultrasonographic criteria for gastroschisis were defined as a defect in the anterior upper abdominal wall, usually right paraumbilical side, with a normal umbilical insertion on the abdominal wall, not covered by visible membrane, with fetal intestine floating freely within the amniotic cavity. As a differential diagnosis, omphalocele was defined as a central upper anterior abdominal wall defect covered by a membranous sac that contains the herniated organs, with the umbilical cord insertion at its apex.
Fetuses with other structural anomalies (prenatally diagnosed) were excluded. The mothers were submitted to amniocentesis during routine amnioexchange, and 40 ml of amniotic fluid were collected for biochemical and genetic testing. Twenty milliliters were used for both conventional and molecular cytogenetics assays. The study was approved by the institutional Ethic Committee and the pregnant women involved have signed an informed consent term.
Standard phenol-chloroform DNA extraction with alcohol precipitation was carried out, and the conservation of high molecular weight of the extracted DNA was examined through a 1% agarose electrophoresis gel.
Normal lymphocyte metaphases were obtained according to routine protocols for karyotyping. DNA indirect labeling of fetal cells (target, green) and normal (reference, red) DNA and hybridization was carried out as described elsewhere [9] . Reversal labeling was carried out whenever possible to check the CGH results. Briefly, equal amounts of test DNA (from the gastroschisis fetuses) and normal DNAs (from a normal sex-matched donor) were ethanol-coprecipitated with unlabeled Cot-1 DNA, dissolved in hybridization buffer (50% formamide/10% dextran sulfate/2 ! SSC, pH 7), denatured at 75 ° C for 5 min and applied into normal lymphocyte metaphase preparations. The hybridization procedure took place at 37 ° C for 72 h in a humid chamber. Post-hybridization washes included washes with 0.4 ! SSC at 75 ° C for 2 min and 0.1% NP-40, 2 ! SSC for 2 min at room temperature. Counterstaining was achieved with 4 ,6-diamidino-2-phenylindole (DAPI; Vector Laboratories) in an antifade solution.
Either two different CGH softwares performed image analysis: Cytovision (Applied Imaging, San Jose, Calif., USA) and CGH View (Applied Spectral Imaging, San Diego, Calif., USA) coupled in an Olympus (Tokyo, Japan) or Zeiss (Jena, Germany) fluorescence microscope. Target regions were defined according to the green/red ratio. Chromosomal regions where the mean ratio was ! 0.8 were considered to reflect losses of DNA and regions where the mean ratio was 11.2 were considered to reflect gains. Highlevel amplification was assigned if the ratio exceeded 1.5.
Results
Amniotic samples from seven pregnant women were analyzed through conventional cytogenetics (G-banding) and molecular cytogenetics (CGH). The mean gestational age at the procedure time was 29 weeks (28-31). All fetuses displayed a normal G-band karyotype. Six of them displayed a normal disomic profile through CGH with no preferential genomic gains or losses, confirming the karyotype findings obtained through conventional cytogenetics. One sample has displayed chromosomal gain at the terminal region of chromosome 3 ( fig. 1 ) and assigned as ish cgh enh 3q26 ] qter according to the ISCN nomenclature. This abnormality was not observed through means of conventional karyotyping. After birth, that newborn with the abnormality in chromosome 3 was reassigned as having ruptured omphalocele instead of gastroschisis, because of the presence of amniotic and peritoneum membranes herniated through the defect, with the umbilical cord not inserted on the abdominal wall.
Discussion
CGH is a wide-genome screening test based on a competitive hybridization between a test and a normal DNA that are labeled with green and red fluorochromes onto metaphase spreads. Imbalances as gains or losses will be shown as a difference in the fluorochrome ratio along the chromosome. As the analysis is software-based and requires a specific microscopic workstation and expensive laboratory reagents, the technique demands specialized molecular cytogenetics expertise, which is not widespread in non-developed countries. CGH may be used for prenatal diagnosis and may address many of the limitations of the conventional cytogenetics techniques [10] . Also it might be used as a 'search tool' for chromosomal imbalances as the results will show amplification and deletion patterns in the whole genome. The minimal size of chromosomal gains and losses that CGH is capable to detect ranges from 5 to 10 MB and is closely related to the banding resolution level of the metaphase spreads where the DNA is hybridized. Other molecular techniques such as FISH and arrays might be used after CGH has been performed to study refined DNA targets in specific regions [2] . Array-CGH has also been applied more recently and promises to solve many unsolved questions regarding gene status in the prenatal period [11] .
Omphalocele and gastroschisis are both included into the group of congenital abdominal wall defects, although cytogenetics have shown them not to be similar. Recent works have associated gastroschisis much more to environmental factors and omphalocele to gene factors. As reported at the EUROCAT registers [12] , gastroschisis is less prevalent than omphalocele (0.94 per 10,000 and 2.52 per 10,000, respectively), although omphalocele is more likely to be associated with other defects and chromosomal imbalances. Etiology factors suggested to contribute to gastroschisis include some teratogens such as tobacco, alcohol, cocaine, aspirin, ibuprofen and epidemiologic associations such as young maternal age, short interval between menarche and first pregnancy, low socioeconomic status, poor maternal education suggesting a strong correlation with epigenetic and environmental factors [13] .
Regarding genetic factors, very few have been reported, such as the association with aneuploidy and familial cases in a very sporadic fashion. Recently, a functionally null deletion at the mouse bone morphogenic protein-1 (BMP-1) gene resulted in a phenotype that resembled human gastroschisis. BMP-1 became the first potential candidate gene for gastroschisis, but mutational analysis through polymerase chain reaction, single-strand conformation polymorphism and direct sequencing methods showed no mutations of the gene in patients with gastroschisis [14] . To date, no genes have been indicated as possible candidates for gastroschisis.
Our present study has suggested that screening through both conventional and molecular cytogenetics is not indicated for isolated gastroschisis in accordance with others [15, 16] . In our center, we have been performing fetal karyotyping of all omphalocele cases and gastroschisis cases only if associated with other defects. The fetuses in this study presented isolated gastroschisis, normal G-band karyotype and normal genomic profile through CGH. We verified one case with a genomic imbalance, which was later on classified as omphalocele.
After we have achieved the present results, we investigated cytogenetic data from all gastroschisis and omphalocele fetuses attended in our service from 1995 to 2005. Previous data show conventional karyotype investigation of 2 gastroschisis and 34 omphalocele of which 1 and 10 displayed chromosomal abnormalities, respectively. Interestingly, we found out that in 1995 we observed a 46,XX,add(3)(q26) karyotype in a fetus with omphalocele and Dandy-Walker cyst which supports our present results and the role of the region 3q in omphalocele even though we have failed to detect the same alteration in our gastroschisis patients.
Yatsenko et al. [17] described a case of omphalocele, dysmorphic features and mild developmental delay associated with a maternally-derived unbalanced translocation between chromosomes 3 and 4 resulting in trisomy for region 3q27.3. They also performed a literature review analyzing the association between duplication of the long arm of chromosome 3 and omphalocele. They identified 94 cases of partial trisomy 3q (including the one they had described in the paper), from 65 families, with 13 cases associated with omphalocele. Using bacterial artificial chromosome probes in FISH studies, the group defined a small region in the terminal portion of chromosome 3 that could contain one or more genes important in normal abdominal wall development.
We presented here an interesting example of the use of CGH to investigate fetuses with structural abnormalities, as a new tool for prenatal diagnostic. To the best of our knowledge, this is the first study using CGH in fetuses with gastroschisis. Further studies are needed to elucidate the role of 3q in the omphalocele etiology. We suggest the use of FISH probes and microarrays based on bacterial artificial chromosomes spanning the 3q24-qter region in order to refine the search for a candidate gene for omphalocele. Conventional karyotyping is indicated for omphalocele if isolated or in association with other defects. If a normal karyotype is achieved, high-resolution banding or molecular techniques should be considered in order to exclude structural abnormalities that, with the common aneuploidies, have been shown to be of importance for the onset of omphalocele.
